zevra_inline_fullcolor_rgb_12in@300ppi (1).png
Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
March 28, 2024 16:32 ET | Zevra Therapeutics
Launch of OLPRUVA® underway Topline results from KP1077 phase 2 study demonstrate clinically meaningful benefits for key IH symptoms Q4 2023 net revenue of $13.2M, and FY 2023 net revenue of $27.5M ...
Applied Therapeutics logo.jpg
Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia
March 28, 2024 16:30 ET | Applied Therapeutics
NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...
pyxis logo.jpg
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 28, 2024 16:30 ET | Pyxis Oncology
BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers,...
Shapeways.png
Shapeways Reports Fourth Quarter and Full Year 2023 Results
March 28, 2024 16:29 ET | Shapeways, Inc.
- Expands Q4 2023 Gross Margins to 46% and Increases Gross Profit by 23% vs the same quarter in the prior year -- Continues to Explore Strategic Alternatives to Maximize Shareholder Value - NEW YORK,...
logo.png
Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023
March 28, 2024 16:28 ET | Centessa Pharmaceuticals plc
Hemophilia Program: Ongoing registrational PRESent-2 and PRESent-3 studies of SerpinPC for the treatment of hemophilia B; PRESent-2 advancing toward interim analysis planned in 2024Orexin Agonist...
NaaS Technology Inc. Reports Unaudited 2023 Fourth Quarter and Full Year Financial Results
March 28, 2024 16:15 ET | NaaS Technology Inc.
BEIJING, March 28, 2024 (GLOBE NEWSWIRE) -- NaaS Technology Inc. (“NaaS” or the “Company”) (Nasdaq: NAAS), the first U.S. listed EV charging service company in China, today announced its unaudited...
wintrust-out-2color-rgb.png
Wintrust Financial Corporation Announces First Quarter 2024 Earnings Release Schedule
March 28, 2024 16:15 ET | Wintrust Financial Corporation
ROSEMONT, Ill., March 28, 2024 (GLOBE NEWSWIRE) -- Wintrust Financial Corporation ("Wintrust") (Nasdaq: WTFC) today announced it will release first quarter 2024 earnings results after the market...
UNCY Logo.jpg
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update
March 28, 2024 16:15 ET | Unicycive Therapeutics, Inc.
– Oxylanthanum Carbonate (OLC) Topline Data Expected in Q2 2024 – – UNI-494 Granted Orphan Drug Designation in Delayed Graft Function of Acute Kidney Injury – – UNI-494 Phase 1 Single Ascending Dose...
eaglebancorpinc.jpg
Eagle Bancorp, Inc. Announces Cash Dividend
March 28, 2024 16:15 ET | Eagle Bancorp, Inc.
BETHESDA, Md., March 28, 2024 (GLOBE NEWSWIRE) -- Eagle Bancorp, Inc. (the “Company”) (NASDAQ: EGBN), the parent company for EagleBank, today announced a cash dividend for the first quarter of 2024,...
IB Acquisition Corp. Announces Closing of $115,000,000 Initial Public Offering, Including Full Exercise of Underwriter Over-Allotment Option
March 28, 2024 16:15 ET | IB Acquisition Corp.
Boca Raton, Florida, March 28, 2024 (GLOBE NEWSWIRE) -- IB Acquisition Corp. (NASDAQ: IBACU) (the “Company”) announced today the closing of its initial public offering of 11,500,000 units, which...